Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme Article

Ford, Judith M, Seiferheld, Wendy, Alger, Jeffrey R et al. (2007). Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 69(3), 831-838. 10.1016/j.ijrobp.2007.04.017

Industry Collaboration

cited authors

  • Ford, Judith M; Seiferheld, Wendy; Alger, Jeffrey R; Wu, Genevieve; Endicott, Thyra J; Mehta, Minesh; Curran, Walter; Phan, See-Chun

sustainable development goals

authors

publication date

  • November 1, 2007

webpage

published in

keywords

  • CARMUSTINE
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • Oncology
  • RANDOMIZED-TRIAL
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • TEMOZOLOMIDE
  • TEXAPHYRIN
  • THERAPY
  • WHOLE-BRAIN RADIATION
  • glioblastoma multiforme
  • glioma
  • motexafin gadolinium
  • radiation enhancer
  • radiotherapy

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 831

end page

  • 838

volume

  • 69

issue

  • 3